相关实验视频

Updated: Jul 7, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

CCRL2缺乏和脂质失调:对HSCT allo后的血小板缺血的影响

Fei Yang¹, Xi Jia², Ying Liu²

¹Department of Clinical Laboratory, Children's Hospital of Soochow University, Suzhou 215025, Jiangsu Province, China.

|April 4, 2025

概括

基因细胞类似受体2 (CCRL2) 在干细胞移植后对血小板的产生至关重要. 较低的CCRL2水平与血小板数量较低和大胆小细胞形成受损相关,特别是与失脂症相关.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
移植生物学移植生物学

背景情况:

同源性造血干细胞移植 (allo-HSCT) 对血液学疾病至关重要.
血小板缺血 (TP) 和脂质失调是常见的,有害的Allo-HSCT并发症.
化基因 (c-c动机) 类似受体2 (CCRL2) 在移植后血栓形成中的作用仍然未被阐明.

研究的目的:

在失脂症条件下的血栓形成中研究CCRL2的功能.
确定CCRL2,脂质代谢和血小板生成之间的关系.

主要方法:

RNA测序确定了骨髓细胞中差异表达的基因.
通过ELISA测量了血栓形成素 (TPO) 和化学素水平.
使用CCRL2和ApoE双淘汰赛小鼠来评估炎症性细胞因子,巨核细胞 (MK) 聚化和活性氧物种 (ROS).

主要成果:

在TP患者中,CCRL2的降低调节与失脂血症和细胞因子风暴.
在小鼠中,CCRL2缺乏减少了血小板数量和高排卵性MKs.
在CCRL2缺乏的小鼠中观察到减少ROS和增加自.

结论:

CCRL2和脂质平衡是血栓形成的组成部分.
CCRL2可能是预防TP后合金-HSCT的治疗标.

关键词:

在 ApoEEE 中.在CCRL2中使用.全源性造血干细胞移植 (allo-HSCT) 的方法血小板缺血症 (TP) 是一种发生血栓形成的过程.

更多相关视频

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...